Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hewlett Packard Enterprise CoHPE · Entity 2984 | Director | May 01, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hewlett Packard Enterprise Co
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,750 |
Reported balance
After 2026-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-01 · Grant · Acquired 8,750 · Balance 8,750 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. |
| Common StockSEC Table I · non-derivative | Direct | 55,850 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 55,850 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F2: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 12,396 · Balance 0 F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 1,022 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
ZYNGA INC
Report date May 23, 2022 · Filed May 24, 2022
Section 16 reporting ended · disclosed 2022-05-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-23 transaction · row 1
1 source rowRow 1 · 2022-05-23 · Disposition to issuer · Disposed 210,183 · Balance 0 F1: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations. F2: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations.
F2: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2020 Filed Feb 11, 2020 16:03 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008267 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 17:42 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 60,000 | $6.21 | $372,600.00 |
DisclosureSEC source: 0001209191-19-060947 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,262 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/18/2019. F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $6.20 to $6.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 18:24 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 60,000 | $6.28 | $376,800.00 |
DisclosureSEC source: 0001209191-19-057321 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,262 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/18/2019. F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $6.27 to $6.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 19:28 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055874 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,420 Underlying: Class A Common Stock · 8,210 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 7, 2019, November 7, 2019, and February 7, 2020, and 25% of the restricted stock units vest on the earlier of May 7, 2020 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 19:28 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055874 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 19:18 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 61,191 | $6.16 | $376,936.56 |
DisclosureSEC source: 0001209191-19-053510 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,052 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan. F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $6.11 to $6.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 18:56 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045402 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,630 Underlying: Class A Common Stock · 8,210 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 7, 2019, November 7, 2019, and February 7, 2020, and 25% of the restricted stock units vest on the earlier of May 7, 2020 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 18:56 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045402 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| May 07, 2019 Filed May 9, 2019 16:20 UTC | ZYNGA INC ZNGA · Entity 126967 | GrantRestricted Stock Unit · Derivative | 32,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-028475 · doc4.xml · derivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,840 Underlying: Class A Common Stock · 32,840 shares Expires 2026-05-07 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 7, 2019, November 7, 2019, and February 7, 2020, and 25% of the restricted stock units vest on the earlier of May 7, 2020 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 18:01 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026638 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 14,535 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 18:01 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026638 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:42 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007289 · form4.xml · derivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 Underlying: Common Stock · 1,243 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:35 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 2,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006152 · form4.xml · derivative · entry 4 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,990 Underlying: Common Stock · 2,384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F4 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, or termination/retirement date. F4 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, or termination/retirement date. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:35 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006152 · form4.xml · nonDerivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 20:35 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006152 · form4.xml · derivative · entry 3 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,441 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 11, 2019 Filed Feb 14, 2019 20:35 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006152 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2019 Filed Jan 29, 2019 18:04 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-005859 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,535 Underlying: Class A Common Stock · 14,535 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| January 26, 2019 Filed Jan 29, 2019 18:04 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-005859 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 18:38 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-056464 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,070 Underlying: Class A Common Stock · 14,535 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 18:38 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-056464 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| July 26, 2018 Filed Jul 26, 2018 18:09 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044080 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,605 Underlying: Class A Common Stock · 14,534 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| July 26, 2018 Filed Jul 26, 2018 18:09 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044080 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 19:22 UTC | ZYNGA INC ZNGA · Entity 126967 | GrantRestricted Stock Unit · Derivative | 58,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026732 · doc4.xml · derivative · entry 3 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,139 Underlying: Class A Common Stock · 58,139 shares Expires 2025-04-26 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F4 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 19:22 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 7,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026732 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,006 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. F3 · balance_after: Reporting Person and Issuer mutually agreed to cancel the remaining 27,837 shares of Issuer's Class A Common Stock subject to this restricted stock unit award. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 19:22 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 7,006 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-026732 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 21:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-006221 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,374 Underlying: Common Stock · 1,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 13, 2015. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 13, 2015. Vested shares will be delivered to the reporting person the earlier of three years from the grant date, or termination/retirement date. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 21:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-006221 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2018 Filed Feb 12, 2018 20:13 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005270 · form4.xml · derivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441 Underlying: Common Stock · 1,441 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 9, 2019, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 01, 2018 Filed Mar 15, 2018 21:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 34,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020041 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,843 Underlying: Class A Common Stock · 34,843 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| February 01, 2018 Filed Mar 15, 2018 21:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 34,843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-020041 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 16:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 34,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-059150 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,686 Underlying: Class A Common Stock · 34,843 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 16:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 34,843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-059150 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:27 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 34,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047563 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,529 Underlying: Class A Common Stock · 34,843 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:27 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 34,843 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-047563 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| May 01, 2017 Filed May 3, 2017 19:55 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 139,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-029833 · doc4.xml · derivative · entry 3 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,372 Underlying: Class A Common Stock · 139,372 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F3 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 01, 2017 Filed May 3, 2017 19:55 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-029833 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,084 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of September 9, 2016, December 9, 2016, and March 9, 2017, and 25% of the restricted stock units vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 01, 2017 Filed May 3, 2017 19:55 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-029833 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 17:54 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-019935 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,084 Underlying: Class A Common Stock · 19,084 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: The restricted stock units vest as follows: 25% of the shares vest on September 9, 2016, 25% of the shares vest on December 9, 2016, 25% of the shares vest on March 9, 2017 and 25% of the shares vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 17:54 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-019935 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 17:20 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007783 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,326 Underlying: Common Stock · 2,161 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, or termination/retirement date. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 21, 2014. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, or termination/retirement date. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 17:20 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007783 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:16 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantDeferred Stock Units · Derivative | 1,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005649 · form4.xml · derivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,487 Underlying: Common Stock · 1,990 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change of control. F3 · balance_after: Includes deferred stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Deferred stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share. Read SEC document |
| December 09, 2016 Filed Dec 9, 2016 18:39 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-154524 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,168 Underlying: Class A Common Stock · 19,084 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: The restricted stock units vest as follows: 25% of the restricted stock units vest on September 9, 2016, 25% of the restricted stock units vest on December 9, 2016, 25% of the restricted stock units vest on March 9, 2017 and 25% of the restricted stock units vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| December 09, 2016 Filed Dec 9, 2016 18:39 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-154524 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| September 09, 2016 Filed Sep 9, 2016 18:46 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-140827 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,252 Underlying: Class A Common Stock · 19,083 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: The restricted stock units vest as follows: 25% of the shares vest on September 9, 2016, 25% of the shares vest on December 9, 2016, 25% of the shares vest on March 9, 2017 and 25% of the shares vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| September 09, 2016 Filed Sep 9, 2016 18:46 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-140827 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.